 |
|
|
| |
Cost-effectiveness analysis of a new paradigm to
simplify testing, monitoring and treatment of hepatitis C
virus in the United States
|
| |
| |
EASL 2023 June 21-24 Vienna
Douglas T. Dieterich1, Nancy S. Reau2, Aijaz Ahmed3, Rob Blissett4, Adam Igloi-Nagy4, Alon Yehoshua5. 1Institute for Liver Medicine, Mount Sinai Health System, United States; 2Rush University Medical Center, Department of Hepatology, Chicago, United States; 3Stanford University School of Medicine, Division of Gastroenterology and Hepatology, Stanford, United States; 4Maple Health Group, LLC,
New York, United States; 5Gilead Sciences, Inc, United States
|
| |
|
|
|
|
|
